About
Theranica is an Israeli biomedical technology company founded in 2016, focused on prescribed digital therapeutics for pain management, particularly migraine treatment. The company develops non-invasive, drug-free wearable devices that combine neuroscience research with mobile digital solutions to deliver personalized pain relief. The flagship product, the Nerivio device, is a smartphone-controlled wearable that delivers electrical pulses to treat acute migraine attacks in adults. This FDA-approved device offers a clinically proven alternative to traditional migraine medications and is designed for ease of use, promoting patient engagement through connected care and personalized feedback. Theranica also provides a connected care platform that collects anonymized patient data to enhance treatment adherence and outcomes, supporting healthcare providers in managing patient care effectively. Theranica primarily targets migraine sufferers seeking effective, drug-free treatment options, especially those who do not respond well to conventional medications. The company is expanding its operations in the US and aims to reach more patients and healthcare professionals with its innovative migraine therapy.
Technologies
Keywords
Company Information
-
Employees 89
-
Founded 2016
-
Total Funding $41000000
Location
100 Somerset Corporate Blvd, Bridgewater, New Jersey, United States, 08807-2834
